Affiliation:
1. Growth and Development Unit, University of Oxford, University Field Laboratory, Wytham, Oxford OX2 8QJ, United Kingdom
Abstract
To evaluate contributions of catecholamines to inhibition of growth during chronic hypoxemia or severe undernutrition, epinephrine (Epi; 0.25–0.35 μg ⋅ kg−1 ⋅ min−1) or norepinephrine (NE; 0.5–0.7 μg ⋅ kg−1 ⋅ min−1) was administered to normoxemic fetuses in twin-pregnant ewes for 8–12 days, from 125 to 127 days of gestation. Both had similar effects and decreased fetal weight by ∼20% relative to control twins ( P < 0.01). Weight gain ceased during infusion of Epi or NE (−21 ± 14.8 or 14 ± 20.9 g/day), whereas controls gained 93 ± 13.2 g/day ( P < 0.01). Effects on tissues and organs varied, spleen and thymus being most retarded, whereas brain weight and skeletal measures were affected little. Selected muscles from infused fetuses weighed 72% of those in controls. Growth ceased during infusion ( P < 0.001). Weight gain of hindlimb bones was negligible, but length increased at 56% of control rates. Arterial blood CO2and plasma insulin were decreased ( P< 0.001), but plasma glucose, growth hormone, and blood oxygenation increased ( P < 0.001). Actions of Epi and NE could underlie asymmetrical growth retardation occurring in many adverse physiological situations during fetal development.
Publisher
American Physiological Society
Subject
Physiology (medical),Physiology